Table 2. Antifungal drug susceptibility testing of Aspergillus ustus isolates.
Isolate | Amphotericin B* | Voriconazole* | Itraconazole* | Caspofungin† |
---|---|---|---|---|
Patient 1 | 2.0 | 8.0 | 4.0 | 2.0 |
Patient 2 | 2.0 | 4.0 | 2.0 | 2.0 |
Patient 4 | 2.0 | 8.0 | 4.0 | 4.0 |
Patient 5a | 1.0 | 4.0 | 2.0 | 8.0 |
Patient 5b | 1.0 | 8.0 | 8.0 | 4.0 |
Patient 5c | 2.0 | 8.0 | 4.0 | 2.0 |
Patient 6 | 2.0 | 8.0 | 8.0 | 2.0 |
Lung transplant | 2.0 | 4.0 | 1.0 | 2.0 |
Environment | 4.0 | 8.0 | 4.0 | 2.0 |
*MIC 100, μg/mL. †Minimum effective concentration, μg/mL.